Posts Tagged 'allergan'

As Women Call for Action, FDA Continues “Assessment” of Breast Implant Cancer Risk

FDA continues assessment of breast implant cancer riskA growing number of women are being diagnosed with a form of breast cancer linked to breast implants, and the calls for lawsuits and legislative action or regulation are rising.

16 deaths may already be associated with the condition known as BIA-ALCL or breast-implant associated anaplastic large cell lymphoma. U.S. diagnoses of the cancer are now up to 457 from a previous high of 414. Over ...

continue reading...

IBS-D Drug Could Threaten Patient Safety after Single Day’s Use

viberzi dangerous after one dayFor those who suffer from irritable bowel syndrome with diarrhea, or IBS-D, the trouble is two-fold. Physically, they endure severe abdominal pain and possible nausea on a regular basis, as well as excessive amounts of gas and sudden urges to reach the nearest bathroom. But they also face potential embarrassment over their condition and can suffer anxiety and loss of appetite. These social aspects can have dramatic impacts on their quality of ...

continue reading...

IBS-D Drug Could Kill Those Without Gallbladder

viberzi may cause fatal pancreatitis in patients with no gallbladderMay 27, 2015 was a busy day at the FDA and a good day for two competing pharmaceutical companies. Allergan’s Viberzi, as well as Valeant’s Xifaxan medications were both approved by the agency to treat IBS-D, or irritable bowel syndrome with diarrhea.

Patients suffering from irritable bowel syndrome must contend with frequent agonizing bouts of lower stomach distress. The pain can be intense and is amplified by the ...

continue reading...